Literature DB >> 34297273

Effect of TiO2 on Selected Pathogenic and Opportunistic Intestinal Bacteria.

Ewa Baranowska-Wójcik1, Dominik Szwajgier2, Klaudia Gustaw2.   

Abstract

Food-grade titanium dioxide (TiO2) containing a nanoparticle fraction (TiO2 NPs-nanoparticles) is widely used as a food additive (E171 in the EU). In recent years, questions concerning its effect on the gastrointestinal microbiota have been raised. In the present study, we examined interactions between bacteria and TiO2. The study involved six pathogenic/opportunistic bacterial strains and four different-sized TiO2 types: three types of food-grade E171 compounds and TiO2 NPs (21 nm). Each bacterial strain was exposed to four concentrations of TiO2 (60, 150, 300, and 600 mg/L TiO2). The differences in the growth of the analyzed strains, caused by the type and concentration of TiO2, were observed. The growth of a majority of the strains was shown to be inhibited after exposure to 300 and 600 mg/L of the food-grade E171 and TiO2 NPs.
© 2021. The Author(s).

Entities:  

Keywords:  Bacterial; E171; Microbiota; Nanoparticles; TiO2 NPs

Mesh:

Substances:

Year:  2021        PMID: 34297273      PMCID: PMC9023387          DOI: 10.1007/s12011-021-02843-7

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   4.081


Introduction

Titanium dioxide (TiO2) is an oxide of white metal used as a food additive (E171) due to its whitening and brightening properties. Since it contains nano-fractions [1, 2], the additive raises increasing concerns about the risk of disruption of the intestinal barrier and dysbiosis of the intestinal microflora [3, 4]. For example, France was the first country to prohibit the use of this food additive for fear of its negative effects on the human organism [5]. Besides commensal bacteria, the gastrointestinal microbiome is regularly exposed to food-borne (transient) bacteria, which may also come into contact with TiO2 via ingestion or passage of food through the intestine [6, 7]. This may exert an effect on the resident microbiome and, consequently, on human health. Investigation of the interactions between bacteria and TiO2 can provide considerable amounts of valuable information. There are only few studies assessing the interactions of NPs with intestinal microflora and their effect on host health. Most research is focused on direct interactions with intestinal epithelial cells [8, 9] and a vast majority of studies concerned modified TiO2. In the present study, we focused on the effect of unmodified TiO2 NPs applied in food production on selected pathogenic and opportunistic intestinal bacteria (Table 1). The aim of the experiment was to reproduce, as accurately as possible, the probable conditions (i.e., bacterial and TiO2 concentrations) in which intestinal bacteria come into contact with this food additive.
Table 1

List of bacterial strains under study

Species and strain
1. Escherichia coli DH5α
2. Bacillus subtilis PCM 486
3. Micrococcus luteus DSM 20,030
4. Salmonella anatum ATCC 9270
5. Salmonella enterica ATCC 10,708
6. Listeria monocytogenes ATCC 35,160
List of bacterial strains under study

Material and Methods

Nanoparticles

Four types of TiO2 were used in the study. Food-grade TiO2 (E171) was purchased from three Polish suppliers: Warchem Sp z o.o., Marki; Biomus, Lublin; and Food Colors, Piotrków Trybunalski (nos. 1, 2, and 3, respectively). For comparison purposes, TiO2 NPs were purchased from Sigma-Aldrich (CAS Number: 718467-100G. Titanium (IV) oxide, nanopowder, 21 nm) (no. 4). The characteristics of the studied TiO2 are presented in our earlier work [10].

Sample Preparation

Aqueous suspensions of each TiO2 type were prepared daily, before each experiment, in deionized water (60, 150, 300, and 600 mg/L; a, b, c, and d, respectively). Next, each sample was subjected to 30-min sonication in an ultrasonic bath (25 °C, 250 W, 50 Hz).

Bacterial Cultures

Pure MRS media, as well as media with the addition of nanoparticles at four concentrations (a, b, c, d), were prepared. The growth of bacteria (Table 1) was controlled for 72 h by measurements of the optical density (OD) at 600 nm every 2 h using Bioscreen C (Labsystem, Helsinki, Finland) as in Gustaw et al. [11]. Control variants were performed in each experiment (samples lacking bacteria or NPs). The comparison of these values showed the inhibitory properties of the particular types of nanoparticles and their concentrations. On the basis of the results obtained, growth kinetics values were determined using the PYTHON script for individual strains and each medium variant used (Supplementary materials, Fig. 2S1-2S6) [12].

Results

The monitoring of the bacterial growth for 72 h revealed the differences in the inhibition of the strains, depending on the type and concentration of TiO2 (Figs. 1, 2; Supplementary materials, Fig. 1S1). The percentage inhibition was directly proportional to the increasing concentration of the nanoparticles, in comparison with the control.
Fig. 1

Growth of selected bacteria after application of four types of TiO2 at the concentration of 300 (A, C, E), 600 (B, D, F) mg/L; E171 (nos. 1, 2, 3), TiO2 NPs (no. 4)

Fig. 2

Growth of selected bacteria (M. luteus) after application of four types of TiO2 at the concentrations of 60 (A), 150 (B), 300 (C), and 600 (D) mg/L; E171 (nos. 1, 2, 3), TiO2 NPs (no. 4)

Growth of selected bacteria after application of four types of TiO2 at the concentration of 300 (A, C, E), 600 (B, D, F) mg/L; E171 (nos. 1, 2, 3), TiO2 NPs (no. 4) Growth of selected bacteria (M. luteus) after application of four types of TiO2 at the concentrations of 60 (A), 150 (B), 300 (C), and 600 (D) mg/L; E171 (nos. 1, 2, 3), TiO2 NPs (no. 4) There were differences in the growth of E. coli, B. subtilis, and S. anatum on the Luria–Bertani medium supplemented with the four different types of TiO2 at the concentration of 300 mg/L (Fig. 1A, C, E) and relatively high differences at the exposure to the highest concentration of 600 mg/L (Fig. 1B, D, F). Escherichia coli turned out to be the most resistant of these three species to the negative effects of the NPs, as no growth inhibition was detected at the concentrations of 30 and 150 mg/L, and the max OD value at the concentration of 600 mg/L decreased by half (Table 2). This was also visible in the growth kinetics of this strain, as the duration of the lag phase differed by only 1 h at the highest concentration. In turn, B. subtilis proved to be almost as susceptible to growth inhibition as M. luteus. Evident growth inhibition was noted at the lowest concentration; however, this species adapted to the unfavorable environment over time and exhibited a similar growth rate as that in the control.
Table 2

Bacterial growth parameters (600 mg/L); E 171 (nos. 1, 2, 3), TiO2 NPs (no. 4)

speciesTypes of TiO2 NPsLag time (hours)Max specific growth rate (hours−1)Doubling time (hours)Max ODMin ODR2
M. luteusControl6.670.164.380.830.021.00
1n.gn.gn.g0.140.00n.g
2n.gn.gn.g0.120.00n.g
3n.gn.gn.g0.170.00n.g
4n.gn.gn.g0.040.00n.g
E. coliControl6.770.079.380.640.051.00
16.560.0419.450.310.020.99
27.200.0417.410.280.000.99
37.320.0323.350.320.040.98
47.910.0321.490.320.010.98
B. subtilisControl6.770.079.380.640.051.00
1n.gn.gn.g0.190.02n.g
2n.gn.gn.g0.210.00n.g
3n.gn.gn.g0.190.00n.g
4n.gn.gn.g0.170.00n.g
S. anatumControl7.820.193.570.910.000.97
10.000.0611.630.620.020.98
20.000.079.650.740.030.99
30.000.079.660.650.020.98
40.000.0415.450.700.050.96

n.g., no growth

Bacterial growth parameters (600 mg/L); E 171 (nos. 1, 2, 3), TiO2 NPs (no. 4) n.g., no growth The S. enterica and L. monocytogenes strains did not substantially inhibit the growth of bacteria after the application of all types and concentrations of TiO2. The slightest differences in the case of all other strains were noted after the application of the lowest concentrations (60 and 150 mg/L) (Fig. 1S1). The growth curve for the bacteria cultured on the medium supplemented with these two concentrations of all types of nanoparticles (1, 2, 3, 4) was similar to that in the control. An exception was the M. luteus strain, whose growth was inhibited already at the lowest concentration (60 mg/L) (Fig. 2A), and significant growth inhibition was noted after the exposure to nanoparticle 1 (Fig. 2). This strain exhibited substantial growth reduction in all experimental variants, and the increasing concentration was accompanied by an increasing percentage of growth inhibition, relative to the control, until the growth was suppressed completely at the highest concentration.

Discussion

This study demonstrated that the four different types of TiO2 applied at the concentrations of 300 mg/L and 600 mg/L inhibited the growth of four bacterial strains. Interestingly, at the 300 mg/L concentration, there were evident differences in the bacterial responses to the different E171/NPs TiO2 forms used in the experiment (Figs. 1 and 2). As demonstrated in our work as well as by other authors in the past, both the type and concentration of TiO2 may have an influence on the outcome of the experiment. However, taking into account our results and the results of other authors cited in this discussion, it can certainly be assumed that, indeed, TiO2 influences the growth of the discussed microorganisms. As reported by Sani et al. [13], the minimum inhibition concentrations of TiO2 nanoparticles (anatase, purity < 99%) for L. monocytogenes (IBRC-M 10,671), E. coli O157:H7 (IBRC-M 10,698), and S. enteritidis (IBRC-M 10,954) were 2, 3, and 3 mg/mL, respectively. Bacillus subtilis (wild type 3610 strain) growth was slightly decreased by 13 μg/mL of TiO2 NPs (Sigma-Aldrich, 700,347, anatase:rutile 80:20, < 150-nm particle size), after 72 h of cultivation (zones of inhibition in soft-solid agar LB medium) [14]. Both food-grade E171 TiO2 NPs and Aeroxyde P25 (NM-105, mixed crystalline, 85% anatase:15% rutile, mean particle diameter of 22 ± 1 nm) were added at 32–320 μg/mL to batch cultures in non-irradiated conditions induced dose-dependent inhibition of the growth of E. coli K12 MG1655. In the case of food-grade E171 at 320 μg/mL, TiO2 NPs caused complete inhibition of the growth of E. coli after 20 h of the cultivation [15]. Pure TiO2 NPs (D = 13 nm) inhibited the growth of E. coli and Enterobacter cloacae, as shown using the disc diffusion method, but no sophisticated calculations using statistical tools were performed in that study [16]. In another study, TiO2 NPs (40 ± 10 nm, 60 ± 10 nm, and 80 ± 10 nm) were tested against S. typhimurium and E. coli. At 50 μg/mL, the 40 nm, 60 nm, and 80 nm TiO2 NPs induced 3.96, 4.45, and 7.15% cell death, respectively. At the concentration of 250 μg/mL, TiO2 NPs caused a 10% increase in the killing rate, compared to 50 μg TiO2/mL, but the trend was similar at both concentrations applied. Similar results were obtained for the S. typhimurium population, where the killing percentage was nearly 3% at the 50 μg/mL concentration and varied to 2 decimal places only. However, in the S. typhimurium population treated with TiO2 NPs with mean diameters of 60 nm and 80 nm, the killing rate increased 2–threefold along with the higher dose of NPs applied (250 vs. 50 μg NPs/mL) [17]. Khan et al. [18] isolated from chocolate and characterized TiO2 NPs with an average size of ~ 40 nm. The isolated TiO2 NPs decreased the growth of probiotic bacteria (Bacillus coagulans, Enterococcus faecalis, and Enterococcus faecium) over a concentration range of 125, 250, and 500 μg/mL in vitro (plate method). At the concentration of 500 μg TiO2/mL, NPs inhibited the growth of the probiotic formulation by 66 ± 6.1% and 71 ± 5.6% in anaerobic and aerobic conditions, respectively. Significant reduction in the count of E. coli (ATCC 8739), Salmonella paratyphi (ATCC 9150), and L. monocytogenes (ATCC 15,313) (reduction log CFU 0.95 ± 0.01, 0.66 ± 0.01, and 0.58 ± 0.01, respectively) by TiO2 NPs (15–50 nm, 0.1 mg/mL in the solution) was observed by Anaya-Esparza et al. [19]. Ripolles-Avila et al. [20] reported that both anatase (crystal phase, 7 nm) and a combination of anatase–rutile (80:20 wt/wt, 21-nm size) in the range from 0.78 to 100 μg TiO2/mL of nutrient broth significantly reduced the growth of S. enterica var. enteridis, E. coli, S. aureus, and B. cereus in a dose-dependent manner. Sroila et al. [21] prepared 5-, 16-, and 26-nm TiO2 NPs and showed that, in the dark, 1–6 nm TiO2 NPs (crystal form of anatase, mean diameter 5 nm, at the highest concentrations applied equally to ~ 22.73 μg/mL) were efficient inhibitors of the growth of E. coli after 4 h of incubation. The authors concluded that TiO2 NPs can diffuse into the cell membrane of E. coli and disorganize the cell membrane, leading to deformation of the cell and disorganization of intracellular structures. The minimum inhibition concentrations of TiO2 NPs (purity 99%, tetragonal shape, 10 ~ 25 nm in diameter) for the growth of E. coli, S. enteritidis, and L. monocytogenes were 2.00 ± 0.33, 2.50 ± 0.17, and 1.00 ± 0.14 mg/mL, respectively [22]. Lately, Arezoo et al. [23] reported an inhibitory effect of TiO2 NPs (with particle size < 20 nm), incorporated in sago-based starch film on the growth of E. coli and Salmonella typhimurium. However, in their experiments, the film was complex and cannot be directly compared with our studies. As it can be seen, the above-cited authors reported on the reduction in the growth of bacteria in the presence of TiO2. In selected cases, we obtained similar results as other authors, concerning the effective concentrations of TiO2 that may have an influence on bacterial growth [15, 17, 20], 22. However, there are also some discrepancies between our results and other, above-cited works [13, 14, 19, 21]. These differences can be due to several reasons that must be discussed. First, the authors used various methods of bacterial detection (qualitative disc method, zones of inhibition, absorbance measurement, etc.). Secondly, various titanium dioxides were used (food-grade mixtures from various producers, with an undefined particle size distribution, or TiO2 NPs with a well-defined size in a very narrow range). Thirdly, although we and the cited authors have tested bacteria of the same genus, the outcome may be species/strain dependent. Due to all these factors, the comparison of the results must be made with the awareness of their existence. Another issue is the analysis of how TiO2 affects the growth of bacteria. Unfortunately, we do not have more detailed information yet, what factors determine the reduction of growth and propagation of bacteria in the presence of TiO2, this knowledge is also not included in the cited works. Last but not least, some studies demonstrated that TiO2 NPs had no influence on the growth of discussed microorganisms. Escherichia coli (ATCC8099) was not inhibited by P25 TiO2 NPs (anatase–rutile, 21 ± 5 nm) at 0.15 mg NPs/plate [24]. Similarly, Liu et al. [25] observed no inhibition of the growth of E. coli by pure TiO2 NPs at 0.5 g/L in the dark and under the light. Rokicka-Konieczna et al. [26] showed no inhibition of the growth of E. coli K12 (ATCC 29,425) in the dark in the presence of 0.1 g/L of TiO2 NPs (anatase, crystallite size 14 nm). Sethi and Sakthivel [27] showed no inhibition of the growth of E. coli by pure anatase (titania) in the dark in the presence of 0.5 mg/mL of TiO2 NPs. Aguas et al. [28] showed no inhibition of the growth of E. coli by commercial TiO2 (P25, anatase/rutile = 80/20) suspended in the solution at the concentration of 50 mg TiO2 NPs/L. No inhibition of the growth of E. coli and S. paratyphi A in the dark was observed in the presence of TiO2 NPs [29]. The average nanoparticle size specified by the authors based on their previous study was 8–20 nm [30].

Conclusion

The complexity and variability of microbiota species in each human impede the assessment of the effect of food additives on this ecosystem. The present study has demonstrated inhibition of bacterial growth caused by both food-grade E171 and TiO2 NPs in most of the analyzed strains, at concentrations similar to those reported by a number of other authors. However, there are also discrepancies between works, concerning the effective concentrations of TiO2. The methods of detection of microorganisms, the type of TiO2 (food grade or NPs), or species/strain variability may influence the outcome of the study. Due to these factors, it is necessary to check the mechanism of action of TiO2 on the bacterial cell; therefore, further investigations in this field are indispensable for elucidation of the potential toxicity of NPs to the human microbiome. (ZIP 8.20 MB) (DOCX 438 KB)
  23 in total

Review 1.  Fate, activity, and impact of ingested bacteria within the human gut microbiota.

Authors:  Muriel Derrien; Johan E T van Hylckama Vlieg
Journal:  Trends Microbiol       Date:  2015-04-01       Impact factor: 17.079

2.  Superior disinfection effect of Escherichia coli by hydrothermal synthesized TiO2-based composite photocatalyst under LED irradiation: Influence of environmental factors and disinfection mechanism.

Authors:  Na Liu; Qi Zhu; Nan Zhang; Cheng Zhang; Naoki Kawazoe; Guoping Chen; Nobuaki Negishi; Yingnan Yang
Journal:  Environ Pollut       Date:  2019-01-28       Impact factor: 8.071

3.  Antimicrobial activity of ZnO-TiO2 nanomaterials synthesized from three different precursors of ZnO: influence of ZnO/TiO2 weight ratio.

Authors:  Ikram Daou; Najia Moukrad; Omar Zegaoui; Fouzia Rhazi Filali
Journal:  Water Sci Technol       Date:  2018-03       Impact factor: 1.915

4.  Whey protein isolate/cellulose nanofibre/TiO2 nanoparticle/rosemary essential oil nanocomposite film: Its effect on microbial and sensory quality of lamb meat and growth of common foodborne pathogenic bacteria during refrigeration.

Authors:  Mahmood Alizadeh Sani; Ali Ehsani; Mohammad Hashemi
Journal:  Int J Food Microbiol       Date:  2017-03-28       Impact factor: 5.277

5.  Four Types of TiO2 Reduced the Growth of Selected Lactic Acid Bacteria Strains.

Authors:  Ewa Baranowska-Wójcik; Klaudia Gustaw; Dominik Szwajgier; Patryk Oleszczuk; Bożena Pawlikowska-Pawlęga; Jarosław Pawelec; Justyna Kapral-Piotrowska
Journal:  Foods       Date:  2021-04-25

6.  Impact of nanoparticles on the Bacillus subtilis (3610) competence.

Authors:  Elise Eymard-Vernain; Sylvie Luche; Thierry Rabilloud; Cécile Lelong
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

7.  Kinetics Analysis and Susceptibility Coefficient of the Pathogenic Bacteria by Titanium Dioxide and Zinc Oxide Nanoparticles.

Authors:  Mahmood Alizadeh-Sani; Hamed Hamishehkar; Arezou Khezerlou; Mohammad Maleki; Maryam Azizi-Lalabadi; Vahid Bagheri; Payam Safaei; Taher Azimi; Mohammad Hashemi; Ali Ehsani
Journal:  Adv Pharm Bull       Date:  2019-12-11

8.  Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes.

Authors:  Chenhong Zhang; Muriel Derrien; Florence Levenez; Rémi Brazeilles; Sonia A Ballal; Jason Kim; Marie-Christine Degivry; Gaëlle Quéré; Peggy Garault; Johan E T van Hylckama Vlieg; Wendy S Garrett; Joël Doré; Patrick Veiga
Journal:  ISME J       Date:  2016-03-08       Impact factor: 10.302

9.  Toxicity of Food-Grade TiO2 to Commensal Intestinal and Transient Food-Borne Bacteria: New Insights Using Nano-SIMS and Synchrotron UV Fluorescence Imaging.

Authors:  Joanna M Radziwill-Bienkowska; Pauline Talbot; Jasper B J Kamphuis; Véronique Robert; Christel Cartier; Isabelle Fourquaux; Esther Lentzen; Jean-Nicolas Audinot; Frédéric Jamme; Matthieu Réfrégiers; Jacek K Bardowski; Philippe Langella; Magdalena Kowalczyk; Eric Houdeau; Muriel Thomas; Muriel Mercier-Bonin
Journal:  Front Microbiol       Date:  2018-04-24       Impact factor: 5.640

Review 10.  Factors Conditioning the Potential Effects TiO2 NPs Exposure on Human Microbiota: a Mini-Review.

Authors:  Ewa Baranowska-Wójcik
Journal:  Biol Trace Elem Res       Date:  2021-01-14       Impact factor: 3.738

View more
  1 in total

1.  Smoothies Reduce the "Bioaccessibility" of TiO2 (E 171) in the Model of the In Vitro Gastrointestinal Tract.

Authors:  Ewa Baranowska-Wójcik; Dominik Szwajgier; Izabela Jośko; Bożena Pawlikowska-Pawlęga; Klaudia Gustaw
Journal:  Nutrients       Date:  2022-08-25       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.